BULLETIN Incorporating Journal of Electrophysiological Techniques

VOLUME 31,1993 AUTHOR AND KEYWORD INDEX

Pergamon Press New York l Oxford l Seoul l Tokyo

Incorporating Journal of Electrophysiological Techniques

Editor-in-Chief MATTHEW J. WAYNER

Division of Life Sciences, The University of Texas at San Antonio, 6900 North Loop 1604 West, San Antonio, Texas 78249-0662

Editorial Advisory Board

ANDERS BJORKLUND, University of Lund, Lund, Sweden LARRY L. BUTCHER, University of California,

Los Angeles, CA TERRY M. DWYER, University of Mississippi Medical

Center, Jackson, MS DAVID L. FELTEN, University of Rochester Medical Center,

Rochester, NY H. C. FIBIGER, The University of British Columbia,

Vancouver, B.C., British Columbia, Canada FRED H. GAGE, University of California, San Diego,

La Jolla, CA DWIGHT C. GERMAN, University of Texas Southwestern

Medical Center, Dallas, TX GLENN I. HATTON, University of California, Riverside, CA MILES HERKENHAM, National Institute of Mental Health,

Bethesda, MD DAVID M. JACOBOWITZ, Department of Health & Human

Services, Bethesda, MD BARRY L. JACOBS, Princeton University, Princeton, NJ ABBA J. KASTIN, Veterans Administration Medical Center,

New Orleans, LA KIYOSHI KATAOKA, The University of Ehime School of

Medicine, Shigenobu, Onsen-Gun, Ehime, Japan HENRY KHACHATURIAN, National Institute of Mental

Health, Rockville, MD S. T. KITAI, University of Tennessee, Memphis,

Memphis, TN EDMUND F. LA GAMMA, Children’s Medical Center at

Stony Brook, Stony Brook, NY JOHN C. LIEBESKIND, The University of California,

Los Angeles, CA JAMES M. LIPTON, University of Texas Southwestern

Medical Center, Dallas, TX SAMUEL M. MCCANN, University of Texas Southwestern

Medical Center, Dallas, TX

RICHARD B. MAILMAN, University of North Carolina School of Medicine, Chapel Hill, NC

PETER J. MORGANE, Worcester Foundation for Experimental Biology, Shrewsbury, MA

ROBERT D. MYERS, East Carolina University School of Medicine, Greenville, NC

DWIGHT M. NANCE, University of Manitoba, Winnipeg, Manitoba, Canada

ANDRES NEGRO-VILAR, Department of Health & Human Services, Research Triangle Park, NC

STYLIANOS NICOLAIDIS, College de France, Paris, France TAKETOSHI ONO, Toyama Medical and Pharmaceutical

University, Toyama, Japan YUTAKA OOMURA, Institute of Bio-Active Science,

Hyogo, Japan MARY LOU OSTER-GRANITE, University of California,

Division of Biomedical Sciences, Riverside, CA DONALD W. PFAFF, The Rockefeller University,

New York, NY PAUL R. SANBERG, University of South Florida College of

Medicine, Tampa, FL MICHAEL T. SHIPLEY, University of Cincinnati Medical

Center, Cincinnati, OH ALBERT SIMPSON, Showa University, Shinagawaku,

Tokyo, Japan THEODORE SLOTKIN, Duke University Medical Center.

Durham, NC L. W. SWANSON, University of Southern California,

Los Angeles, CA TIMOTHY J. TEYLER, Northeastern Ohio Universities

College of Medicine, Rootstown, OH CHARLES D. WOODY, University of California at

Los Angeles, Los Angeles, CA IAN S. ZAGON, M. S. Hershey Medical Center, Hershey, PA

BRAIN RESEARCH BULLETIN Production Editor.

Kathleen M. Major, Pergamon Press, Tarrytown, NY

Publishing, Subscription and Advertising Ojices: Pergamon Press Inc., 660 White Plains Road, Tarrytown, NY 1059 l-5 153, USA, INTERNET “PPI@PERGAMON.COM”

and Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, England

Published 18 per annum (monthly with 2 issues published in January, February, March, April, July, and September) Annual institutional subscription rate (1993): f740 (US$1406.00)

Sterling prices are definitive. US dollar prices are quoted for convenience only, and are subject to exchange rate fluctuation. Prices include postage and insurance and are subject to change without notice.

Brain Research Bulletin, Vol. 31, pp. 757-761, 1993 Printed in the USA. All rights reserved.

0361-9230/93 $6.00 + .OO Copyright 0 1993 Pergamon Press Ltd.

AUTHOR INDEX

McRitchie, D. A., I7 1 Meek, J., 229 Mtndez, M., 621 Meredith, M., 369 Miettinen, R., 3 1 I Miki, T., 57 Mikkelsen, J. D., 4 15 Miletic, V., 523, 53 1 Mintz, M., 641 Mirmiran, M.. 67 , -. Mitchell, C. L., 733 Miyoshi, S., 57 Mohankumar, P. S., 745 Mohringe, B., 463 Molina, V. A., 161 Moons. L.. 231 d

Moran; J.,‘62 1 Mora, F., 305 Morimoto, A., 287 Morimoto, M., 673 Morzorati, S., 301 Mullen, B. G., 7 13 Murakami, N., 287 Murtagh, F. R., 115

Aalders, T. T. A., 229 Achermann, P., 97 Adams, F., 655 Adler, M., 201 Aguirre, J. A., 279 Aimar, P., 601 Akaishi, T., 7 19 Alba, F., 393 Albrecht, D., 455 Auland. J. P.. 20 I A& Y:, 63 1 Araki, T., 85 Arenas, J. C., 393 Arendash. G. W.. 115 Arilla, E.,’ 165 Armario, A., 29 Aste, N., 60 1

Doetsch, G. S., 553 Dougherty, P. M., 49 1 Draao, F.. 485 Droiet, G., 737 Duindam, H., 145 Dyck, D. G., 39

Jackson, G. L., 2 17 Jacobowitz. D. M.. 13 Jansen, H. T., 2 17’ Jonak, Z. L., 565 Jonakait, G. M., 49 Joseph-Bravo, P., 62 1

Eckel, L. A., 6 13 Egawa, M., 293 Emerich, D. F., 267

Kaba, H., 701 Kanai, H.. 85 Kannan, H., 135 Kanterewicz, B. I.. 66 1 Kastin, A. J., 707 Kato, H., 84 Kawano, S., 135 Kawarabavashi. T.. 68 1 Kawata, M., 4d5 Kelland, M. D., 539 Keller, E. A., 16 1 Keller, J. T., 7 13 Kellogg, C. K., 353 Kelly, P. A. T., 581 Kimura-Takeuchi, M., 33 Kindel, G., 129 Kiyohara, T., 68 1 Knowlton. B. J.. 641 Knox, A. P., 477 Kobari, M., 443 Kogure, K., 85 Koizumi. K.. 405 Kostrzewa, R. M., 707 Kruse-Larsen, C., 4 15 Kubek, M. J., 301 Kuriyama, K., 68 1

Factor, E. M., 49 Ferrari. R.. 23 Ferrarib, C. M., 195 Feuerstein, G. Z., 565 Fiedler, J. A., 115 Fish, C. J., 565 Foidart, A., 60 1

Balthazart, J., 601 Barnes, K. L., 195 Barnes. M. I.. 733 Barone, F. C~, 565 Barraco, R. A., 397 Baskin. D. G.. 36 1 Batten; T. F. C., 233 Battles, A. H., 477 Bazil, M. K., 273 Benassi, C., 23 Bennett, B. A., 47 1 Berry, P. A., 233 Besson, M. J., 723 Biral, G. P., 23 Bitran, D., 353 Blatteis, C. M., 509 Block, F., 9 1, 449 Boer, G. J., 145 Boix. F.. 655 Bon&o& E. A., 115 Borbely, A. A., 97 Borghese, C. M., 697 Bos, N. P. A., 67 Breton, P., 723 Brunner, D. P., 97

Fonda, S., 23 Frank, C.. 375. 501 Freedman, L. J., 749 Freeman, A. S., 539 Fukui, Y., 57 Fukuuchi, M., 443 Fukuyama, T., 38 1

Gabriel, H.-J., 455 Gavald, A., 29 Gean, P.-W., 7 Genazzani, A. A., 485 Georgieva, J., 463 Golombek, D. A., 66 1 Gbmez. R. A.. 697 Gonzalez-Baron, S., 279 Gordon, F. J., 273 Grassi. M.. 485 Greenberg: A. H., 39 Grioffioen, H. A., 145 Grubin, C. E., 361

Nagai, K., 293 Nakagawa, H., 293 Nakanishi, H., 667 Nakashima, T., 68 1 Nance, D. M., 39 Nardo, L., 485 Narvkz, J. A., 279 Niel, J.-P., 627 Nio, J., 723 Nishino, H., 433 Nishizuka, M., 63 1 Nitsch, C., 50 1 Noguchi, K., 329 Norelle, A., 553 Normile, H. J., 397

Lahtinen H., 3 11 Lappi, S. E., 319 Larsen, P. J., 415 Lee, E. H. Y., 253 Lee. E. V.. 565 L&g, G., 405 Li, B.-H., 43 Li. C.-S.. 587 Li; Q., 433 Lin, J.-H., 7 Lin, J.-Y., 587 Lin, R. C. S., 553 L6ezCalder6, A., 29 Lu, G.-W., 523, 531 Lu. K. T..253 Lu; S. M.; 553 Luthman, J., 463

Cardinali, D.P., 66 1 Carpenter, D. O., 477 Chang, F. W., 253 Chang, F.-C., 7 Charli, J.-L., 62 1 Chen, X. H., 57 Chiaraviglio, E., 1 Chiodo, L. A., 539 Clark. R. K.. 565 Clarke, L. P.1 115 Clerc, N., 627 Conner-Kerr. T. A.. 573 Coveiias, R. 279 Cristi, C., 5 15 Curtis, A. L. 737

Halonen, T., 3 11 Hanesworth, J. M., 649 Hanin, I., 129 Hansen, L., 129 Harding, J. W., 649 Hart. R. P.. 49 Hattori, S.,‘433 Heim, C., 9 1 Hirakawa, N., 673 Hoffert, M. J., 523 Hoffpauir, J., 225 Homma, S., 719 Hoxtnagl, H., 129 Huang, C. C., 7 Huston, J. P., 655

O’Hare, M. T., 415 Okada, R., 63 1 Okamura, H., 637 Olschowka, J. A., 353 Ono, K., 209 GRegan, M. H., 547 Osaka, T., 135 Ossenkopp, K.-P., 6 13

Pan, J.-T., 587 Panocka, I., 595 Panzica, G. C,60 1 Paris. J. M.. 471 ra 1

Parizon, M:, 397 Partlo, L. A., 437 Peano, C. A., 493 Pecora, J. R., 47 1 Perez-Oso, E., 165 Perkins, L. M., 547 Philip, R., 58 1 Phillis, J. W., 547 Pineda, J. A., 689 Pinch, J. H., 73 Pompei, P., 595 Popiela, C. L.. 2 17

Magnusson, O., 463 Maqbool, A., 233 Marcos, P., 279 Mark, E. K., 553 Martens. K. A.. 397 Marti, d., 29 Massi, M., 595 Matsui, N., 433 Matsunaga, K., 329 Matsuoka, S., 443 Mattioli. R.. 655 Mauceri; F.; 485 Mayo-Michelson, L., 345 McQueeney, A. J., 195

Ibata, Y., 637 Ichitani, Y., 637 Iizuka, R., 63 1 Inenaga, K., 135 Inglefield, J. R., 353 Inout. S.. 33. 293 Iribar; C.; 393 Ison, A., 405 Itoh, M., 57 Iwamoto, G. A., 2 17

Dafny, N., 49 1 Davidowa. H.. 455 De Carolis, A.’ S., 375 De Lebn, M., 279 Denbow. D. M.. 121 Dijk, D.iJ., 97 Dillon, G. H., 493

757

758 1NDEX

Porras, A., 305 Price, W. J.. 565

Quadri, S. K., 745

Rabkin, S. W., 427 Raithbv. A.. 5 IS Ramire;, M., 393 Ramirez. 0. A., 697 Ren, K.. t 3 Riekkinen, Sr., P. J., 3 I 1 Rietveld, W. J., 145 Ritchie, I. M., 58 1 Roberts, K. A., 649 Romanovsky, A. A., 509 Rosenstein, R. E., 66 1 Rowland, N. E., 43 Rubin. J.. 539 Ruda, M.’ A., I3

Sagratella, S., 375, 501 Sainsbury, R. S., 437 Saito, H.. 701 Sakata, Y., 287 Satoh, S., 293 Schmidt-Kastner, R., 9 I

Schneider, B., 129 Schwarting, R. K. W., 655 Schwartz, M. W., 36 1 Schwartz, T. W., 4 15 Schwarz. M.. 449 Schweitzer. L.. 225 Scotti, A. L.. 501 Scotti-De Carolis, A.. 50 I Seidler, F. J., 3 19 Senba, E., 329 Sengstock, G. J., I 15 Seto. K.. 701 Sharkey. J., 581 Sheppard, B. J., 121 Sheridan, R. E.. 201 Shido. 0.. 509 Shin. T.. 38 1 Shindou. T., 667 Shonis, C. A., 493 Sieklucka. M., 91 Sipols, A. J., 36 1 Siotkin. T. A.. 3 19 Smith, D. A.. I IS Snider, M.. 5 I5 Sontag, K.-H., 91, 449 Stackman. R. W.. 267 Standage, G. P., 553 Strominger. L.. 477 Stubley, L. A.. 649

Tork, I., 171 Takamura. Y.. 293 Takeda, H., 443 Takeuchi, Y.. 57 Tamer, A. E.. 129 Tanahashi, N., 443 Tanaka, M.. 637 Tanaka. Y.. 637 Tanner. C.. 5 15 Taylor, L. A.. 267 Terrian, D. M., 573 Thyagarajan, S., 745 Tohvama. M.. 329 Tokunaga, A., 209 Tomita. M., 443 Tonelli, L., 1 Totoki. T.. 673 Tramu, G.. 279 Tsuda. M. 209

Ueta, Y ., 135,405 Umezaki, T.. 38 I Ungar. A. L., 509

Valentino, R. J., 737 Valerio. C., 485 Van Der Woude. T. P.. 145 Vanderwolf, C. H., 5 IS Vandesande. F., 233

Velasco. A.. 27V Viglietti-Panzica, C.. 60 1 Vriend. C. Y.. 39

Waldrop. T. Cr., 493 Walsh. T. J.. 267 Wang, S. D.. 253 Watanabe, S., 667 Way. L.-J., 7 Weaver. S. P., 225 Westerfield, M.. 689 White, J., 369 White, R. F., 565 Wilk, S., 62 I Wright. J. W.. 649

Yamamoto. K., 667 Yamashita, t-i., 135, 405 Yamawaki, T.. 443 Yi, H.. 749 Ylinen. A.. 3 I 1 Young. G. A., 345 Yu, G.-Z.. 70 I Yuri. K., 405

Zeng, Y. c‘.. 375 Zionel. U., 455 Zuccarello, M.. 7 13 zuo. L.. 39

KEYWORD INDEX

I-Methy-4-phenyl- 1,2,3,6-tetrahydropyridin 253

5-HIAA, 745 5-Hydrox~p~mine, 233 6-OHDA rat, 433 3,7-Dimethyl-I-pro~ylxanthine, 397

A5 region, 329 Acetylcholine iontophoresis, 455 Acetylcholine, 129, 369,485 Acetylchohnesterase, 17 I Actin, 225 Action potentiais, 53 1 Acute phase response, 287 Addiction, 49 1 Adenosine Aaa receptors, 397 Adenosine, 547 Aggression, 229 A%-mediated drinking, 1 Alcohol preference, 595 Alcohol;30 1 Alcohol-preferring rats, 30 1 Alpha-2 agonist, 689 Alpha-aminoadipic acid, 253 alpha-helical corticotropin-releasing factor

9-41.737 Alphaz, 437 Alzet, 49 Amino acids, 67, 3 11 Aminoneptidase, 393 Amphethamiine, 305 Amygdala, 7, 631, 667 Androaens. 60 I

Anesthesia, 737 An~otensin 11: 195,649 Angiotensin release, 649 Anorexia, 43 Anti-fluoro-gold antibodies. 749 APB, 23 Apomorphine, 477 Arcuiate nucleus, 2 I7 Area postrema, 6 13 Arecoline, 5 15 Aromatization, 601 Arterial pressure, 493 Aspartate, 547 Astrocyte, 253, 565

BALB/c mice, 253 Barium, 573 Baroreceptor reflex, 7 I9 Basal forebrain, 73, 5 15, Bed nucleus of the striata terminalis, 353 Behavior, 345, 477 Benzodiazepines, 267 Beta-carbohnes, 267 Bicuculline. 701 Biological cmck, 67 Birds, 60 1 Blood pressure, 273, 737 Body weight regulation, 36 1 Body weight, 293 Brain localization, 43 Brain opioids, 427 Brain tissue injury, 509

Brain, 233, 361, 393 Brevetoxin, 20 I

c-&r, 329 Calcium, 375, 573 Calcium-binding proteins, 13, 501 Calretinin, 13 Carbachol. 587 Cat, 279, 523, 531, 627 Catalepsy, 707 Catecholamine, 233 Cat~holamine-indu~d cardiac a~h~hmias,

427 CCK, 587 Celiac ganglion, 627 Central afferent pathway, 38 I Central nervous system, 273 Cerebral blood flow, 443 Cerebral &hernia, 85 Cerebral meta~lism, 9 1 Cerebrovascular autoregulation, 58 I CGP 42112A, 195 CGS 2 1680, 397 Chickens, 12 1 Cholecystokinin, 553 Chronic, 463 Circadian rhythms, 67 Clinical scanner, I 15 Cocaine, 49, 58 1 Cochlea, 225 Colchicine, 209, 733 Computer simulation, 369 Conditioned anorexia, 6 13 Conditioned food aversion, 6 13 Conditioning, 73 Confocal microscopy, 749 Cortex, 547 Cortical blood flow, 58 1 Cortical glucose utilization, 58 I Corticotropin-releasing factor, 353, 737 CPON, 4 15 Cresyl violet, 17 1 C~idine-diphosp~~holine. 485 Cytochalasin, 209

D-2-Amino-7-phosphonoheptanoic acid, 273 D, receptor, 707 Dz receptor, 707 Dehydration, I Dentate granule cells, 733 Deoxyglucose, 23 Development, 49 Dexfenfluramine, 43 Diamine, 573 Diazepam, 353 Diencephalon, 279 Distant lesions, 64 I Dopamine, 233, 253, 305,433, 463,471, 587,

595,621,655 Dopamine-@-hydroxylase, 353 Dopaminergic receptor, 16 I Dorsal column, 13 Dorsal hippocampus, 733 Dorsal nucleus of vagus nerve, 17 1 Dorsal raphe nucleus, 539 Dorsal root ganglion, 13, 523, 53 1

Double labeling, 637 DPAT, 539 Drinking behavior, 135 Drinking, 1 Dura mater, 7 I3

EEG power spectra, 345 EEG, 689 Elasmobranch, 369 Electrical stimulation, 287, 491 Electrocorticogram, 5 15 Electron microscopy, 229, 637 Electrophysiology, 201,627, 719 Electrotonic junction, 53 1 Emesis, 477 Emetic sensitivity, 477 Epilepsy, 3 I 1 ERP, 689 Estradiol, 2 17 Estrogens, 60 1 Estrous cycle, 129 Ethylcholine aziridinium (AF64A), 129 Ethylketocyclazocine, 345, 427 Evoked potential, 38 1 Excitatory amino acids, 273,449 Excitatory postsynaptic potentials, 627 Extra spikes, 523 Extracellular recording, 369

Facial nucleus, 57 FAST neurons, 455 Feeding behavior, 293 Feeding, 43 Field potential, 201 Fimb~a-fomix lesion, 3 i 1 Firma oattern. 70 i Fischer-344 inbred rat strain, 345 Flumazenil, 267 Fluoro-gold, 749 Focal ischemia, 565 Food intake, 12 1 Fos, 43 Frontal cortex, 73 Frontoparietal cortex, 165

GABA, 305, 361,493, 547, 587 Ganglionectomy, 13 Ganglionic transmission, 627 Gangliosides, 16 I Gel titration. 415 Gender differences, 129 Gerbil, 85, 501 Gliai fibrillarv acidic orotein. 463 Gliosis, 565 . . Glucose, 293 Glutamate, 547 Glutamic acid decarboxylase, 553 Glutamic acid, 649 Glycine, 305 Guinea pigs, 509

Hair cells, 225 Haloperidol, 165, 595 Head coil, 115 Hearing, 225 Heart rate, 493

759

760 INDEX

Heterogeneity, 701 Hinh affinitv transnort. 267 Hippocam& slice; 201, 501 Hip~campus, 129, 165, 267, 311, 375,437 Histamine, 587 Histology, 463 Horizontal head movements, 64 I HPA axis, 329 HPLC-EC, 745 HRP, 57 Human frontal cortex, 4 15 Human, 171 Hypertension, 493 Hypotension, 737 Hypothalamic neuron, 587 Hypothalamus, 229, 287, 405, 509, 601 Hypoxia, 375

IL-l@, 74s Immediate early genes, 43 Immobilization stress, 29 Immobilization, 329 Immunocytochemistry, 13,279,471, 553,637 Immunofluorescence, 749 Immunohistochemistry, 225,233,405,415 Immunoreactivity, 43 In situ hyb~dization, 36 1 In situ microdialysis, 655 In vitro brain slice, 195

Male, 2 I7 Medial basal hypothalamus, 745 Medial forebrain bundle, 73 Medial preoptic area, 2 I7 Medulla obiongata, i 7 I Metabolism, 23 Methamphetamine, 47 I Methylaxozymethanol, 485 Mice. 397 Microinjection, 649 Microiontophor~is, 67 Midbrain tegmentum, 57 MIF- I. 707 Mitral cell, 70 1 Monkey, 689 Morphine, 49 I Morphometry, 229 Mossy fiber, 573 mRNA, 36 I Multi-unit activity, 369 Muramyl dipeptide, 33 Muscimol, 135

Neocortex. I Neostriatum. 305.655

N-ethoxycarbonyl-2-ethoxy-1,2dihydroquino- line (EEDQ), 16 I

N-methyl-D-as~mte, 7 N-methyl-D-as~~ate receptor, 667 Ng-Monomethyl-L-ar~nine, 443 NECA. 397

Parabrachial nucleus, 43

Prostaglandins, 509

Paralemniscal zone, 57

Protein kinase inhibitor. 209

Pamvent~~ular nucleus, 329, 353,649,681

Psvchostimulant, 581

PD 123177, 195

Push-pull cannula, 649

Pedunculopontine tegmental nucleus, 539

Push-pull perfusion, 305, 745

Peptidase. 62 I

Pyroglutamyl peptidase fl, 621

Perforant path stimulation, 733 Periaquaductal gray, 57 Peripheral nerve injury. 523 Pharmacology, 689 ~haselus vul~ar~s-leuco~utinin, 229 Phosphodiesterase, 85 Photoelectric method, 443 Pilocarpine, 5 I5 PO2,9 I Polydipsic STR/N mouse, 405 Pontine reticular formation, 641 Ponulation mike. 375 Pit-stimulus inhibition, 70 I Posterior hypothalamus, 493 Potassium, 547 Precursor processing, 4 I5 Prenatal exposure, 353 Preoptic/anterior, 509 Prepotachykinin mRNA, 49 Prepotentials, 53 1 Presynaptic, 573 Primary afferents, 523 proNPY, 4 I 5

In vivo microdialysis, 463

Infarction, 565 Inflammation, 565

Indomethacin. 509

Infusion, 6 13 Inhibition, 1 Inosine, 547 Insulin, 293 Interaction, 33 lnterictal spikes, 3 I I Interleukin- I, 39, 287 Intermediate filaments, 209 lntermediolateral cell column. 329 Intracellular Ca*+, 667 Inverse agonists, 267

Nervus terminalis, 369 Neural transplan~tion, 433 Neurite outgro~h, 209 Neurokinin A, 279 Neurokinins, 655 Neuronal discharges, 67 Neuronal recording, 195 Neuropeptide Y, 145,415,443 Neuropeptides. 7 13 Neurotoxicity, 47 1 Neurotoxins, 129 Neurotrophils, 565 Nicotine effects on brain development, 3 19 Nigrostriatal DA system, 539 Nitric oxide, 443 Nociception, 523 Nonalcohol-prefe~ng rats, 30 I Nonphasi~ly firing neurons, 68 I Norepineph~ne turnover, 39 Norepinephrine, 12 I, 253, 353, 369, 509,689 Novel diet, 6 13 Nucleus accumbens, 397,621,655 Nucleus basalis magnocellularis, 485 Nucleus basalis, 73 Nucleus tractus soiirarii. 195

Raccoon, 553 Raphe cultures, 47 1 Raphe, 49,47 I Rat, 13, 23, 33, 73, 91. 115, 217, 305, 393,

449.455. 501.637.713.719.613.649 Rauwolscine, 569 Receptor autoradiography, 85 Release, 547, 62 I Remodeling, 63 I Restraint stress, 29 Retinal projection, 637 Retrograde tracing, 749 Rh~amine-la~lled microspheres, 649 Righting reflex, 30 1 Risneridone. 595 Ritanserin, 595 Rolipram, 85 Rotation, 64 I Running test, 433

Kainic acid, 57, 135, 515, 573, 641 Ketamine, Mesoaccumbens DA system, 539 Kindling, 63 I

L657,743, 689 L-Dopa, 233 L-glutamate, I95 Lactate, 9 1 Laminen, 463 Larynx, 381 Lateral geniculate nucleus, 455 Lateral preoptic area, 135 Lateral septum, 62 I Learning and memory, 485 Lewis inbred rat strain, 345 LH, 29 Lidocaine, 1 Light-evoked responses, 455 Lithium, 6 13 Local tem~rature, 9 1 Locomotor activity, 397,433 Locus coeruleus, 253 Long-term potentiation, 7, 667 Losartan potassium, 195

Macrophages, 565 Magnetic resonance imaging, I I5

Obesity, 293 Offspring, 165 Olfactory bulb, 70 1 Ornithine decarboxylase in developing brain,

319 Osmoreceptive zones, I ~mo~ulation, 135 Osmotic dehydmtion, 1 Osmotic minipump, 49,6 13 Oxotremorine, 5 15 Oxytocin, 405, 68 I

P3,689 Pain, 329 Paired-pulse inhibition, 375, 501

SCH 23390. 707 Sciatic nerve, 539 Scopolamine, 485 Sedation, 30 I Seizures, 733 Selectively vulnerable areas, 85 Sensorv nrocessina, 523.53 I Septal ekerents, 2% Septum, 30 I Sequential intracerebroventricular

administration, 33 Serotonin, 29,47 1, 587. 595 Sexual behavior, 601 Sexual dimorphism, 601 SHR, 493,565 Single unit activity, 455

INDEX 761

Single units, 7 3 SKF 38393,539 Sleep substance, 33 Slice preparation, 667 Slices, 375 SLOW neurons, 455 Slow potentials, 73 Sodium channel, 20 1 Sodium nitroprusside, 737 Solitary nucleus, 17 1 Somatosensory cortex, 553 Somatosensory-evoked potentials, 449 Somatostatin receptors, 165 Somatostatin, 145, 311, 553 Spectral analysis, 369 Spinal cord, 13, 273 Spiperone, 707 Splenic macrophage, 39 Spontaneous discharges, 523 Stereotyped behavior, 16 1 Streptozotocin diabetic, 7 19 Stress, 329, 737 Striatum, 463 Stroke, 565, 581 Subarachnoid hemorrhage, 7 13 Subfomical organ, 649 Subnuclei, 17 1 Substance P, 49 Substantia innominata, 73

Substantia nigra, 253, 641 Subtype-selective Ang II receptor antagonists,

195, Superior colliculus, 23 Superior laryngeal nerve, 38 1 Suprachiasmatic nucleus, 67, 637 Supraoptic nucleus, 68 1, 7 19 Sympathetic ganglion, 627 Sympathetic nervous system, 273 Sympathetic, 39 Sympathetic-adrenomedullary axis, 329 Synapse, 531,631 Synaptic activity, 523 Synaptic organization, 229 Synaptic reorganization, 3 11 Synaptic transmission, 20 1 Synaptosomes, 573 Synthesizing enzyme, 233

Tacrine, 5 15 Taurine. 305 Teleost hsh, 233 Testosterone, 2 17 TFMPP, 539 Thalamus, 553 Thermoregulation, 509 Theta, 437 Thyrotropin releasing hormone, 62 1 Tolerance, 707

Transplantation, 145 Treadmill, 433 TRH, 301 Triglyceride, 293 Tryptophan hydroxylase, 49 Tyr-MIF- 1, 707 Tyrosine hydroxylase, 463

Unit activity, 2 17 Uptake, 47 1 Urethane, 655, 73 Uridine, 22

Vasoactive intestinal peptide, 637 Vasoactive intestinal polypeptide, 145, 553 Vasopressin, 145,405, 719 Ventral hippocampus, 733 Ventrobasal thalamic nucleus, 449 Ventromedial hypothalamus, 293 Virgin female rat, 68 1 Visual discrimination, 73 Visual system, 455 Vomiting, 477

Water intake, 12 1 Wet dog shakes, 733 Withdrawal, 49 1

Zona incerta, I